Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Recruiting now

Conditions studied: Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome

In brief

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.

Key facts

Study ID
NCT00315380
Run by
University of Pennsylvania
People needed
700
Starts
2006-04-01
Expected to finish
2028-12-01
Last updated by the study team
2026-01-23

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.